This inventor holds 39 USPTO granted patents, primarily in Receptor Antagonists. Top assignees: Smithkline Beecham Corporation, Smithkline Corporation, Smithkline Beckman Corporation. Active years: 1978-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cherry Hill, NJ (US) (1978 - 1988)
- Wayne, PA (US) (1987 - 2003)
Company Filing History:
25 out of 2,198 
7 out of 344 
6 out of 207 Years Active: 1978-2003
Areas of Expertise:
Title: **William Edward Bondinell: Innovator in Protease Inhibition**
Introduction
William Edward Bondinell, a noted inventor based in Wayne, PA, holds an impressive portfolio of 39 patents. His work primarily focuses on the development of innovative solutions aimed at addressing significant health challenges, particularly those related to bone loss and metabolic diseases.
Latest Patents
Among his latest contributions to the field, Bondinell has developed a series of patents related to Vitronectin receptor antagonists and protease inhibitors. The present invention encompasses bis-aminomethyl carbonyl protease inhibitors and their pharmaceutically acceptable salts, hydrates, and solvates. These compounds demonstrate the ability to inhibit proteases, such as cathepsin K, and are pivotal in the treatment of various diseases characterized by excessive bone loss or degradation of cartilage and matrix. Conditions such as osteoporosis, gingival diseases, arthritis (including both osteoarthritis and rheumatoid arthritis), Paget's disease, hypercalcemia of malignancy, and metabolic bone disease can potentially benefit from the therapeutic applications of these innovative compounds.
Career Highlights
Bondinell's career includes significant tenures at both SmithKline Beecham Corporation and SmithKline Corporation. His extensive experience in pharmaceutical development has earned him recognition within the industry for his contributions to health sciences and innovation.
Collaborations
Throughout his career, William Edward Bondinell has collaborated with esteemed colleagues like Thomas Wen-Fu Ku and James Martin Samanen. Together, they have pushed the boundaries of research and development, contributing to advancements in medical therapies.
Conclusion
William Edward Bondinell stands out as a prominent figure in the field of pharmaceutical innovation, particularly through his work on protease inhibitors. His extensive patent portfolio not only reflects his inventive spirit but also his commitment to improving public health through scientific advancements. As such, he remains a valuable contributor to the ongoing dialogue in medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile